Table 1.
Demographic and clinical details, for Indigenous and non-Indigenous patients with cancer of the head and neck in Queensland Australia, 1998- 2004
| Indigenous Status | P value | ||
|---|---|---|---|
| Indigenous N = 67 N % |
Non-Indigenous N = 62 N % |
||
| Cancer site (ICD code) | |||
| Floor of Mouth (C04) | 5 (8) | 7 (11) | |
| Gum (C03) | 1 (2) | 3 (5) | |
| Hypopharynx (C13) | 1 (2) | 2 (3) | |
| Lip, oral cavity, pharynx - ill defined (C14) | 9 (13) | 6 (10) | |
| Nasopharynx (C11) | 3 (5) | 2(3) | |
| Oropharynx (C10) | 5 (8) | 2 (3) | 0.26 |
| Palate (C05) | 8 (12) | 2 (3) | |
| Parotid (C07) | 3 (5) | 7 (11) | |
| Pyriform Sinus (C12) | 7 (10) | 7 (11) | |
| Tongue (C01- C02) | 15 (22) | 20 (32) | |
| Tonsil ( C09) | 5 (8) | 4 (7) | |
| Unspecified Salivary glands (C08) | 1 (2) | 0 | |
| Unspecified mouth (C06) | 4 (6) | 0 | |
| Age | |||
| 18- 39 | 2 (3) | 4 (7) | |
| 40-59 | 40 (60) | 39 (63) | 0.52 |
| 60+ | 25 (37) | 19 (30) | |
| Sex | |||
| Male | 47 (70) | 43 (70) | 0.92 |
| Female | 20 (30) | 19 (30) | |
| Area of remoteness (ARIA) | |||
| Highly accessible | 11 (17) | 7 (11) | |
| Accessible | 9 (14) | 10 (16) | 0.28 |
| Moderately accessible | 25 (37) | 33 (53) | |
| Remote | 9 (13) | 6 (10) | |
| Very remote | 13 (19) | 6 (10) | |
| Socioeconomic status (SEIFA ) | |||
| 1 Most disadvantaged | 26 (39) | 13 (21) | |
| 2 Low to Intermediate advantage | 13 (19) | 20 (32) | |
| 3 Intermediate advantage | 13 (19) | 13 (21) | 0.19 |
| 4 Advantaged | 11 (16) | 12 (19) | |
| 5 Most advantaged | 4 (6) | 2 (3) | |
| 9 Not known | 0 | 2 (3) | |
| Stage at diagnosis (SEER score) | |||
| Localised cancer | 23 (34) | 15 (24) | |
| Regional Spread | 38 (57) | 40 (65) | 0.41 |
| Distant metastasis | 5 (7) | 7 (11) | |
| Not sure | 1 (2) | 0 | |
| Charlson Comorbidity Index (Scores grouped) | |||
| 0 | 42 (63) | 42 (68) | |
| 1 | 16 (24) | 8 (13) | 0.30 |
| 2- 5 | 9 (13) | 11 (18) | |
| 5+ | 0 | 1 (2) | |
| Specific comorbidities | |||
| Diabetes | |||
| No | 59 (88) | 60 (97) | 0.09 |
| Yes | 8 (12) | 2 (3) | |
| Hypertension | |||
| No | 55 (82) | 47 (76) | 0.39 |
| Yes | 12 (18) | 15 (24) | |
| Circulatory disease* | |||
| No | 61 (91) | 51 (82) | 0.19 |
| Yes | 6 (9) | 11 (18) | |
*Cardiovascular or cerebrovascular disease